Patient capital in DC: Worth the risk?

From the blog: Philip Hammond's desire to increase the allocations of defined contribution schemes to 'patient capital', including high-risk venture capital, have proved a divisive issue in the pensions industry.

DC schemes have long clamoured for access to illiquid assets, but the prospect of watered-down protections on costs and charges have had some up in arms.

Pensions Expert asked JLT Employee Benefits' Maria Nazarova-Doyle and the Trades Union Congress' Tim Sharp for their views on whether greater access to patient capital will be a boon or a burden to DC savers’ retirement outcomes.